Psyence Biomedical PBM
NASDAQ PBM
$4.78 -0.06 (-1.14%)
As of: Sep 10, 2026 · 12:35 PM EDT

Psyence Biomedical (PBM) Other Non-Current Assets (2023 - 2026)

Psyence Biomedical (PBM) posted Other Non-Current Assets of $47191.0 for Q1 2026, little changed on a QoQ basis from $47191.0 in Q3 2025, and up 31.22% year-over-year from $35964.0 in Q1 2025.

Analysis

Psyence Biomedical (PBM) Other Non-Current Assets (2023 - 2026) Analysis & Trends

Psyence Biomedical has reported Other Non-Current Assets for 4 years, with the latest figure at $47191.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 31.22% year-over-year to $47191.0 in Q1 2026; TTM through Mar 2026 was $47191.0, a 31.22% increase from a year earlier, with the FY2026 full-year figure at $47191.0, up 31.22% from the prior year.
  • Other Non-Current Assets was $47191.0 for Q1 2026 at Psyence Biomedical, roughly flat from $47191.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $47191.0 in Q3 2025, with the low at -$595172.0 in Q3 2023.
  • Average Other Non-Current Assets over 4 years is -$53706.1, with a median of $29684.5 recorded in 2024.
  • The largest YoY upside for Other Non-Current Assets was 104.98% in 2024 against a maximum downside of 0.33% in 2024.
  • Over 4 years, Other Non-Current Assets stood at -$595172.0 in 2023, then surged by 104.98% to $29611.0 in 2024, then soared by 59.37% to $47191.0 in 2025, then changed by 0.0% to $47191.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $47191.0 (Q1 2026), $47191.0 (Q3 2025), and $35964.0 (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.54 Bn 192.56 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.55 Bn 176.37 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 131.10 Bn 123.25 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.61 Bn 73.62 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.69 Bn 55.51 Bn 1.37 Bn 124.00 Mn
6 Moderna 53.54 Bn 48.40 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.41 Bn 30.10 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.80 Bn 30.52 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.08 Bn 29.08 Bn 1.16 Mn 29.59 Mn
10 Psyence Biomedical 2.64 Mn 2.64 Mn - 47,191.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 47,191.00
Sep 30, 2025 47,191.00
Mar 31, 2025 35,964.00
Sep 30, 2024 29,611.00
Mar 31, 2024 29,684.53
Sep 30, 2023 -595,172.00
Mar 31, 2023 29,587.85